Investor Centre

Pharmaceutical development company Pharmaxis has completed a successful round of engagement at the European Cystic Fibrosis Conference (ECFC) in Gothenburg, Sweden, hosting eight sessions featuring the clinical and practical experience of key cystic fibrosis (CF) clinics with Bronchitol® and involving a global panel of key opinion leaders.